Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03700320
Brief Title: To Evaluate the Safety and Tolerability of Treatment With Atogepant 60 mg Daily for the Prevention of Migraine in Participants With Episodic Migraine

First Submitted : September 25, 2018
First Submitted that Met QC Criteria : October 5, 2018
First Posted : October 9, 2018

Last Update Submitted that Met QC Criteria : March 21, 2019
Last Update Posted : March 25, 2019